Showing posts with label Growing. Show all posts
Showing posts with label Growing. Show all posts

Sunday, 19 March 2017

Growing New Nerves


Today's interesting post comes from sciencedaily.com (see link below) and talks about the work being done in a US research lab to encourage brain cells to create healthy nerves by introducing polymer nanofibres. The 'new' nerves can even grow a myelin layer (the protective sheath around healthy nerves). As with all these things, when they're first reported by researchers, the work is only in very early stages but the potential for 'growing' new nerves to replace damaged ones, or 'repair' damaged nerves themselves, gives hope for treatments of neuropathy in the future. The article is a little 'technical' but still understandable and it may be worth keeping an eye out for any progress in this area.


Researchers Coax Cells to Grow and Myelinate Along Thin Fibers; Potential Use in Testing Treatments for Neurological Diseases
ScienceDaily (Nov. 7, 2012)

Every week in his clinic at the University of Michigan, neurologist Joseph Corey, M.D., Ph.D., treats patients whose nerves are dying or shrinking due to disease or injury.

He sees the pain, the loss of ability and the other effects that nerve-destroying conditions cause -- and wishes he could give patients more effective treatments than what's available, or regenerate their nerves. Then he heads to his research lab at the VA Ann Arbor Healthcare System, where his team is working toward that exact goal.

In new research published in several recent papers, Corey and his colleagues from the U-M Medical School, VAAAHS and the University of California, San Francisco report success in developing polymer nanofiber technologies for understanding how nerves form, why they don't reconnect after injury, and what can be done to prevent or slow damage.

Using polymer nanofibers thinner than human hairs as scaffolds, researchers coaxed a particular type of brain cell to wrap around fibers that mimic the shape and size of nerves found in the body.

They've even managed to encourage the process of myelination -- the formation of a protective coating that guards larger nerve fibers from damage. They began to see multiple concentric layers of the protective substance called myelin start to form, just as they do in the body. Together with the laboratory team of their collaborator Jonah Chan at UCSF, the authors reported the findings in Nature Methods.

The research involves oligodendrocytes, which are the supporting actors to neurons -- the "stars" of the central nervous system. Without oligodendrocytes, central nervous system neurons can't effectively transmit the electrical signals that control everything from muscle movement to brain function.

Oligodendrocytes are the type of cells typically affected by multiple sclerosis, and loss of myelin is a hallmark of that debilitating disease.

The researchers have also determined the optimum diameter for the nanofibers to support this process -- giving important new clues to answer the question of why some nerves are myelinated and some aren't.

While they haven't yet created fully functioning "nerves in a dish," the researchers believe their work offers a new way to study nerves and test treatment possibilities. Corey, an assistant professor of neurology and biomedical engineering at the U-M Medical School and researcher in the VA Geriatrics Research, Education and Clinical Center, explains that the thin fibers are crucial for the success of the work.

"If it's about the same length and diameter as a neuron, the nerve cells follow it and their shape and location conform to it," he says. "Essentially, these fibers are the same size as a neuron."

The researchers used polystyrene, a common plastic, to make fibers through a technique called electrospinnning. In a recent paper in Materials Science and Engineering C, they discovered new techniques to optimize how fibers made from poly-L-lactide, a biodegradable polymer, can be better aligned to resemble neurons and to guide regenerating nerve cells.

They're also working to determine the factors that make oligodendrocytes attach to the long narrow axons of neurons, and perhaps to start forming myelin sheaths too.

By attaching particular molecules to the nanofibers, Corey and his colleagues hope to learn more about what makes this process work -- and what makes it go awry, as in diseases caused by poor nerve development.

"What we need to do for multiple sclerosis is to encourage nerves to remyelinate," he says. "For nerve damage caused by trauma, on the other hand, we need to encourage regeneration."

In addition to Corey, the research has been led by Chan, the Rachleff Professor of Neurology at UCSF, VAAAHS lab team member and U-M graduate Samuel J. Tuck, U-M biomedical engineering graduate student Michelle Leach, UCSF's Stephanie Redmond, Seonook Lee, Synthia Mellon and S.Y. Christin Chong, and Zhang-Qi Feng of U-M Biomedical Engineering.

Peripheral nerves, which have neurons at the center surrounded by cells called Schwann cells, can also be studied using the nanofiber technique. The system could also be used to study how different types of cells interact during and after nerve formation.

Toward creating new nerves, Corey's lab has collaborated with R. Keith Duncan, PhD, Associate Professor of Otolaryngology. Published in Biomacromolecules, they found that stem cells are more likely to develop into neurons when they are grown on aligned nanofibers produced in Corey's lab. They eventually hope to use this approach to build new nerves from stem cells and direct their connections to undamaged parts of the brain and to muscle.

Eventually, Corey envisions, perhaps nerves could be grown along nanofibers in a lab setting and then transferred to patients' bodies, where the fiber would safely degrade.

The research was supported by a VA Merit funding grant, the US National Multiple Sclerosis Society, the Harry Weaver Neuroscience Scholar Award, the Paralyzed Veterans of America and the National Institute of Neurological Disorders and Stroke (NS062796-02).


http://www.sciencedaily.com/releases/2012/11/121107145920.htm

Saturday, 4 March 2017

Neuropathy a Growing Market


Today's post comes from thefreelibrary.com (see link below) and is a report by WWMR, (a world wide marketing research company) first published in 2004. It predicts that by 2012, the market for treatment drugs for neuropathy will top $1 billion in the US, Japan and five major markets in Western Europe. As it's now 2012, I'm curious how accurate the prediction proved to be. Unfortunately, however much money is being earned from the medication of neuropathy, there's still no effective, universal treatment!

Peripheral Neuropathy Market Approaches $1B by 2012; Diabetics, HIV/AIDS and Cancer Patients Drive Growth.

The term peripheral neuropathy encompasses a wide range of disorders in which the nerves outside of the brain and spinal cord—peripheral nerves—have been damaged. World wide peripheral neuropathy, is a recently released report from EP Publications, a service of WWMR (Worldwide Marketing Research), Inc.

This report forecasts the value of the peripheral neuropathy market by drug class, by condition and by country. It describes the commercial potential for current and upcoming drug classes in seven individual countries, the US, Japan and five leading Western European markets. Patient sub- populations associated with diabetes, HIV/AIDS and chemotherapy treatment are estimated through 2012.

More than One Billion Are Affected Patients in the U.S., Europe, and Japan currently suffer the symptoms of this frequently under-diagnosed and irreversible condition each year. This population is projected to surpass 1.5 billion patients through 2012, growing more than 2.5% in these countries each year.

New Agents Hold Promise
-- Until now, hope for the treatment of peripheral neuropathy has relied solely -- and ineffectively -- on ameliorating the symptoms of pain and numbness, and addressing the root cause of the nerve damage. A promising pipeline of therapeutics -- including Eli Lilly's phase IIINoun 1. phase III -inhibitor, ruboxistaurin has the potential to significantly improve the quality of life of those affected.

Pipeline Products Reflect Various Mechanisms of Action

Worldwide, at least 18 agents are in development for treating peripheral neuropathy; these drugs utilize molecular approaches ranging from the reduction of oxidative stress, to stimulate nerve growth

Clinical success of these products would transform the treatment of peripheral neuropathy into a key emerging pharmaceutical market by 2012 in the top seven pharmaceutical country-markets.

Promising new treatments include:

-- Aldose reductase inhibitors epalrestat (Ono Pharmaceutical), fidarestat
(N.K. Curex / Sanwa Kagaku Kenkyusho / Sankyo), zenarestat (Fujisawa /
Pfizer);
-- Carnitine acetyltransferase stimulant levacecarnine / carnitine (Sigma
Tau / GlaxoSmithKline);
-- Cannabinoid receptor antagonist THC:CBD (GW Pharmaceuticals / Bayer
AG); chemoprotectants dimesna (BioNumerik Pharmaceuticals / Baxter
Oncology) and amifostine (MedImmune Oncology);
-- Dopamine receptor agonist uridine (Polifarma / AMINO GmbH);
-- Interleukin-6 (Serono);
-- Nerve growth factor agonist TAK 428 (Takeda);
-- Prosaposin-derived peptide prosaptide TX14 A (Savient Pharmaceuticals);
prostacyclin agonist beraprost (Toray Industries / Kaken);
-- Prostaglandin E agonist liposomal alprostadil (Endovasc Ltd.);

-- Vascular endothelial growth factor VEGF (Caritas St. Elizabeth's
Medical Center of Boston);
-- Copolymer surfactant poloxamer 188 NF (CytRx);
-- Ion channel modulator ABT 202 (Abbott Laboratories / Neurosearch);
-- Protein kinase C inhibitor ruboxistaurin (Eli Lilly); and
-- Drugs including QR 333 (Quigley Corporation), with undefined mechanisms
of action.

About WWMR, Inc.

WWMR, Inc., http://www.wwmr.com/, is an established marketing research and strategic consulting firm
Since 1994, WWMR, Inc., has provided over 1000 insightful, proprietary studies to pharmaceutical, biotech, medical device, and diagnostics companies worldwide. Using primary and secondary research methodologies, WWMR, Inc., provides market and product assessments, competitive intelligence, forecast modeling, patient population projections, product launch monitoring (pre- and post-), primary marketing research and medical economic analyses.
WWMR's other recent reports include:

-- U.S. Neuropathic Pain
-- European Neuropathic Pain
-- Brand Erosion by Generics
-- Rx Brand Erosion by OTC Switches
-- European Pharmaceutical Pricing and Reimbursement
-- Patient Compliance

http://www.thefreelibrary.com/Peripheral+Neuropathy+Market+Approaches+$1B+by+2012%3B+Diabetics,...-a0115037127

Monday, 20 February 2017

GROWING BLOOD VESSEL IN A WEEK



The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown in a new study from Sahlgrenska Acadedmy and Sahlgrenska University Hospital published in EBioMedicine.
Just three years ago, a patient at Sahlgrenska University Hospital received a blood vessel transplant grown from her own stem cells.
Suchitra Sumitran-Holgersson, Professor of Transplantation Biology at Sahlgrenska Academy, and Michael Olausson, Surgeon/Medical Director of the Transplant Center and Professor at Sahlgrenska Academy, came up with the idea, planned and carried out the procedure.
Missing a vein
Professors Sumitran-Holgersson and Olausson have published a new study in EBioMedicine based on two other transplants that were performed in 2012 at Sahlgrenska University Hospital. The patients, two young children, had the same condition as in the first case -- they were missing the vein that goes from the gastrointestinal tract to the liver.
"Once again we used the stem cells of the patients to grow a new blood vessel that would permit the two organs to collaborate properly," Professor Olausson says.
This time, however, Professor Sumitran-Holgersson, found a way to extract stem cells that did not necessitate taking them from the bone marrow.
"Drilling in the bone marrow is very painful," she says. "It occurred to me that there must be a way to obtain the cells from the blood instead."
The fact that the patients were so young fueled her passion to look for a new approach. The method involved taking 25 milliliter (approximately 2 tablespoons) of blood, the minimum quantity needed to obtain enough stem cells.
Blood willingly cooperates
Professor Sumitran-Holgersson's idea turned out to surpass her wildest expectations -- the extraction procedure worked perfectly the very first time.
"Not only that, but the blood itself accelerated growth of the new vein," Professor Sumitran-Holgersson says. "The entire process took only a week, as opposed to a month in the first case. The blood contains substances that naturally promote growth."
More groups of patients can benefit
Professors Olausson and Sumitran-Holgersson have treated three patients so far. Two of the three patients are still doing well and have veins that are functioning as they should. In the third case the child is under medical surveillance and the outcome is more uncertain.
They researchers have now reached the point that they can avoid taking painful blood marrow samples and complete the entire process in the matter of a week.
"We believe that this technological progress can lead to dissemination of the method for the benefit of additional groups of patients, such as those with varicose veins or myocardial infarction, who need new blood vessels," Professor Holgersson says. "Our dream is to be able to grow complete organs as a way of overcoming the current shortage from donors."



Friday, 17 February 2017

Pain For HIV ers A Growing Problem



Today's article from pain.com (see link below) is the first of a week-long examination of living with pain for people living with HIV in general and pays special attention to neuropathy as being one of the main causes of pain. It is useful for people who are experiencing pain, in that it may help identify the cause more easily. The symptoms of neuropathic pain can't really be mistaken for anything else but that's not to say that people with HIV don't also suffer from pain from other sources. 


Treating Pain in the HIV/AIDS Patient


Monday, 13 February 2017

The Growing Problem Of Neuropathy And Cancer Vid


Today's post from livestrong.org (see link below) is directed at people living with neuropathy as a result of cancer treatment. Normally this blog prefers to address all neuropathy sufferers, irrespective of the cause but in this case, cancer has become such a pervasive problem in this day and age, that it can affect anybody with other health problems as well. There has to be space to address cancer-related neuropathy. Much of the information in this article also applies to other neuropathy patients but there is no doubt that cancer-related nerve damage is a growing problem as the cases of cancer rise (better diagnosis and risky  lifestyle habits). Such a shame that the current treatments of cancer can have such devastating side-effects - as if cancer alone wasn't a big enough problem - but we have to live with the cards we are dealt and until chemotherapy is refined to exclude nerve damage, then there is a real possibility that it will cause nerve damage too.
 


Neuropathy
2016 Livestrong


Neuropathy causes tingling or numbness, especially in the hands and feet. It affects about one to two percent of Americans and is caused by damage to a single or multiple nerves. There are different types, but peripheral neuropathy is the most common in those with cancer. 


Peripheral neuropathy may develop at any phase of the cancer journey, even some time after treatment is finished. Knowing what some of the causes are and being able to describe your symptoms to your health care team can help you manage neuropathy. Symptoms are often ignored by both patients and health care professionals. If you have symptoms of neuropathy, it is important to discuss this with your health care team as soon as possible.


Symptoms of Neuropathy

Peripheral neuropathy can affect the nerves that tell you the position of your hands or feet that let you sense hot or cold or that senses pain. You can experience a tingling or numbness in certain areas of the body, commonly the hands and feet. These sensations can range from mild to painful and are almost always greatest at night. 


Common signs and symptoms include:


Numbness or tingling, especially of the hands or feet.
Pain or cramping, especially of the hands, feet or calf muscles.
Sensitivity to touch or temperature.
Loss of reflexes.
Muscle wasting in the hands and feet.
Weakness, especially in the feet or hands.
Clumsiness.
Loss of balance, particularly in the dark.
Dizziness, especially when getting up from a bed or a chair.
Sexual dysfunction.

It’s not easy to deal with neuropathy. If you notice symptoms, talk to your health care team immediately.


Factors that Increase Risk of Neuropathy

Neuropathy may occur from cancer or the treatment received. Cancer types with higher risk of neuropathy include: lung, breast, ovarian, myeloma, lymphoma and Hodgkin's disease and testicular. 


Life factors that may increase the chances of developing neuropathy:


Advanced age.
A family history of neuropathy (such as with familial diabetes).
Malnourishment.
Excessive use of alcohol.
Having a preexisting medical condition such as diabetes or thyroid dysfunction.
Some medications (including chemotherapy medications) also increase risk.
Medications that may increase the risk of neuropathy:
Platinum compounds.
Taxanes.
Vinca alkaloids.
Thalidomide.
Velcade.
Cytosine arabinoside.
Misonidazole.
Interferon.

Discuss all of these risks with your health care team. 


Treatments for Neuropathy

The peripheral nerves have a great ability to heal. Even though it may take months, recovery can occur. However, in some situations, symptoms of neuropathy may lessen but not completely go away. For example, nerve injury caused by radiation often does not recover well. Neuropathy caused by chemotherapy is also difficult to cure, and recovery may take 18 months to five years or longer. During recovery of platinum-induced neuropathy, patients may suffer increased symptoms.

Treatments for peripheral neuropathy depend on the cause. For instance: 

 
If it is related to nutritional deficiencies, supplements may help.
If the neuropathy is related to a medical condition, such as diabetes or thyroid dysfunction, treating the condition can sometimes reverse the neuropathic symptoms.
For neuropathy related to chemotherapy, most treatments are supportive and designed to improve symptoms and function.
If problems develop during treatment and you continue to receive chemotherapy, the neuropathy can get worse.
Clinical trials research shows promise in some treatments with medications that help peripheral nerves to heal and prevent the neuropathy associated with chemotherapy from occurring or being as severe.
Recovery may be helped by:
Good nutrition including foods rich in thiamine, protein and antioxidants.
Controlling and correcting contributing conditions such as diabetes or hypothyroidism.
Appropriate pain medications.
Physical and occupational therapy.


How Neuropathy Affects Your Life

Pain from neuropathy can greatly affect your daily activities and quality of life. Symptoms of neuropathy can range from mild to severe. Each survivor's experience will be different. However, with appropriate treatment, the effects of neuropathy can be limited. 


If you have neuropathy, you may have:
Difficulty standing for long periods or walking without assistance.
Problems with balance and an increased risk of falling.
Difficulty with activities like buttoning and tying laces or ties.
Sensitivity to heat or cold.
Numbness or lack of pain sensation.
Pain.

Survivors with temperature sensitivity should avoid extreme temperatures, and use protective clothing as needed. If there is numbness or an inability to feel pain, it is important to pay careful attention to the skin on the hands and feet because there could be an undetected wound or a break in the skin.

If there is pain, day-to-day activities such as putting on shoes or using covers over the feet at night can be difficult. Keep in mind that there are treatments that can lessen the pain. Talk with your health care team about potential treatments as soon as possible.

If neuropathy affects your ability to feel the foot pedals of a car, you should not drive unless your car is adapted for hand controls. Slowed reaction time in moving your foot from the accelerator to the brake pedal may cause an accident. If you lose the ability to drive, you may feel you are losing your independence. However, consider the increased risk to your safety and to the safety of others.

Ask your health care team to provide suggestions and special equipment to make daily tasks safe and easier to manage. The suggestions may include night lights, grab bars and other home safety measures to help reduce the risk of falling. Physical and occupational therapists can assist survivors with physical exercises that can help them maintain physical abilities.

For some, neuropathy can lead to physical and mental stress. Watch for signs of depression, and seek immediate help from your health care team. Together, you can deal with peripheral neuropathy.

https://www.livestrong.org/we-can-help/finishing-treatment/neuropathy